2015
DOI: 10.1111/joic.12195
|View full text |Cite
|
Sign up to set email alerts
|

A Meta‐Analysis of Sex‐Related Differences in Outcomes After Primary Percutaneous Intervention for ST‐Segment Elevation Myocardial Infarction

Abstract: As compared to men, women undergoing pPCI have more bleedings and strokes, and a worse early, but not mid-term mortality. These findings may allow a better risk stratification of pPCI patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0
10

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 59 publications
1
12
0
10
Order By: Relevance
“…These mechanisms accompanying severe obesity, regardless of the presence of pulmonary hypertension, can promote development of LVH and hormone-driven mechanisms that promote progression of LV remodeling. Another relevant finding in this study is the higher prevalence of LVH of women in this population, since many conducted sex-specific analysis has identified sex differences in the risks of several cardiovascular disease (CVD) outcomes [37,38].…”
Section: Discussionmentioning
confidence: 96%
“…These mechanisms accompanying severe obesity, regardless of the presence of pulmonary hypertension, can promote development of LVH and hormone-driven mechanisms that promote progression of LV remodeling. Another relevant finding in this study is the higher prevalence of LVH of women in this population, since many conducted sex-specific analysis has identified sex differences in the risks of several cardiovascular disease (CVD) outcomes [37,38].…”
Section: Discussionmentioning
confidence: 96%
“…These risk factors may contribute to higher mortality with STEMI. Female sex is known to be an independent predictor of in‐hospital mortality even after adjusting for these variables 26. Although attention needs to be focused on reducing reperfusion times, further research needs to be performed to explore other contributing factors that augment the risk of mortality in female patients when C2D times are comparable between the sexes, such as: (1) investigating preventive strategies to reduce comorbidities in female patients who present with STEMI; (2) analyzing the effectiveness of treatments for comorbid conditions in female STEMI patients, and (3) examining the impact of sex‐based adverse effects of standard treatments for STEMI, which can impact mortality.…”
Section: Discussionmentioning
confidence: 99%
“…Several potential explanations are for the sex differences: (1) women with more cardiovascular risk and older, (2) women with smaller coronary vascular diameter, and (3) more likely to conservative therapy, and different quality of care. [29]…”
Section: Discussionmentioning
confidence: 99%